Topical Finasteride vs Minoxidil for Androgenetic Alopecia

This clinical trial aims to compare the effectiveness of two different topical treatments, finasteride and minoxidil, for addressing androgenetic alopecia, a common type of hair loss affecting both men and women. Traditionally, finasteride is taken orally to block a hormone linked to hair loss, but this study uses it as a topical spray to potentially minimize side effects by targeting the scalp directly. Minoxidil is another topical treatment that helps improve blood flow around hair follicles, encouraging hair growth. The study's goal is to explore which of these treatments is more effective in promoting hair growth, offering valuable insights for those struggling with hair loss. Participants in this study are divided into two groups, each consisting of 95 patients. One group receives a finasteride spray applied to the scalp twice a day, while the other group uses a minoxidil solution in the same manner. Both treatments continue for a period of 12 weeks. The results are evaluated after this period to assess the extent of hair growth improvement in each group. The study takes place in a hospital setting, ensuring that data is collected thoroughly and analyzed using statistical software, which helps in reaching reliable conclusions about the treatments' effectiveness.